ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2 is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 1.4. It has been cited 55 times, with 54 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
0.759
From 39 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 54 citers.
National Cancer Institute
Grant: R01CA222393
American Cancer Society
Grant: RSG-19-229-01-DMC
Cancer Prevention and Research Institute of Texas
Grant: RP190358
National Institute of General Medical Sciences
Grant: R35GM124693
National Institutes of Health
Grant: 1R35GM124693-01
PARP-1 Signaling in DNA Damage and Cell Death
National Institutes of Health
Grant: 5R01CA222393-04
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
FWCI
8.79
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals